Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Aignostics, a Germany-based pathology software spinout of Charité – Universitätsmedizin Berlin and Helmholtz Association of German Research Centres, closed a €5m ($6m) seed round on Friday led by Boehringer Ingelheim Venture Fund, the strategic venturing am for pharmaceutical firm Boehringer Ingelheim. The round was filled out by public-private partnership High-Tech Gründerfonds, Future Capital and VC Fonds Technologie der IBB, a subsidiary of state-run development bank Investitionsbank Berlin. Founded in 2018, Aignostics has built artificial intelligence models intended to help pathologists…